ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in studies exploring cancer biology and therapeutic targets. The research, led by academic groups in Germany, Ireland and the US, supports the system’s growing role in advancing oncology R&D. In one study, published in Journal of […]
The post ANGLE’s Parsortix system used in new cancer biology research appeared first on Pharmafile.
